EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

NF1 Leucine Rich Domain‐Derived Extracellular Vesicles Remodel the Glioblastoma Immune Microenvironment via an ADAM17‐Associated Inflammatory Program

Yuganthini Vijayanathan iD, Jacqueline Yt Yeo, Janice Hy Tan iD, Fikri Bin Mohamed iD, Bernett Lee iD, Tatsuya Kozaki, Nurashikin Abdul Halim iD, Rachel Ly Ho, Hai Tao Tu iD, Zhi Wei Zhang, Jann N Sarkaria iD, Li Zeng iD und 2 weitere

Journal of Extracellular Vesicles · 2026

DOI: 10.1002/jev2.70355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2026. Verfasst von Yuganthini Vijayanathan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Neurotherapeutics Laboratory, National Neuroscience Institute, Singapore, Singapore. Hauptthemen laut MEDLINE: Glioblastoma, Tumor Microenvironment, ADAM17 Protein, Extracellular Vesicles. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Singapore Ministry of Health through the National Medical Research Council (NMRC) Office, MOH Holdings Pte Ltd, Duke-NUS Medical School through the Khoo Bridge Funding Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are increasingly recognized as mediators of intercellular communication in cancer. We previously demonstrated that re‐expression of the leucine‐rich domain (LRD) of neurofibromin (NF1) suppresses glioblastoma (GBM) invasion and limits microglia/macrophage infiltration into the tumor microenvironment (TME). Given the central role of tumor‐associated microglia/macrophages (TAMs) in GBM progression, we investigated whether NF1‐LRD‐containing EVs (NF1‐LRD‐EVs) could modulate TAM function and remodel the TME. Our results showed that NF1‐LRD‐EVs attenuated microglia and macrophage recruitment in migration assays, consistent with reduced microglia/macrophage recruitment observed in vivo . In parallel, treatment with NF1‐LRD‐EVs enhanced phagocytic activity of both microglia and iPSC‐derived macrophages, accompanied by induction of pro‐inflammatory cytokines TNF‐α, IL‐6, and IL‐1β, and downregulation of immunosuppressive mediators such as Arginase‐1 and IL‐10. Mechanistically, NF1‐LRD‐EVs induced ADAM17‐associated inflammatory signaling, accompanied by NF‐κB activation. Pharmacological inhibition of ADAM17 reduced TNF‐α release and attenuated NF‐κB activation, supporting a role for ADAM17‐dependent signaling in amplifying this inflammatory response. Together, these findings show that NF1‐LRD‐EVs reprogram TAMs toward a pro‐inflammatory phenotype and modulate the GBM immune microenvironment. These results provide a framework for understanding NF1‐LRD‐EV‐mediated immune regulation and support further investigation of EV‐mediated immune modulation of the TME.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaTumor MicroenvironmentADAM17 ProteinExtracellular VesiclesNeurofibromin 1Brain NeoplasmsInflammationHumansAnimalsMicrogliaMiceMacrophagesCell Line, TumorNF-kappa B

Stichwörter der Autor:innen

ADAM17NF1TNF‐αextracellular vesiclesglioblastomamacrophagemicroglia

Substanzen

ADAM17 ProteinNeurofibromin 1ADAM17 protein, humanNF-kappa B

Autor:innen und Institutionen

  • Molecular Neurotherapeutics Laboratory, National Neuroscience Institute, Singapore, Singapore.
  • Centre for Biomedical Informatics, Lee Kong Chian School of Medicine, Singapore, Singapore.
  • Singapore Immunology Network, Singapore, Singapore.
  • Infectious Disease Labs (ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
  • Khoo Teck Puat Hospital, Singapore, Singapore.
  • Neural Stem Cells Laboratory, National Neuroscience Institute, Singapore, Singapore.

ORCID-Profile: Yuganthini Vijayanathan, Janice Hy Tan, Fikri Bin Mohamed, Bernett Lee, Nurashikin Abdul Halim, Hai Tao Tu, Jann N Sarkaria, Li Zeng, Florent Ginhoux, Ivy Aw Ho

Förderung

  • Singapore Ministry of Health through the National Medical Research Council (NMRC) Office, MOH Holdings Pte Ltd
  • Duke-NUS Medical School through the Khoo Bridge Funding Award

Zitieren

APA

Vijayanathan, Y., Yeo, J. Y., Tan, J. H., Mohamed, F. B., Lee, B., Kozaki, T., Halim, N. A., Ho, R. L., Tu, H. T., Zhang, Z. W., Sarkaria, J. N., Zeng, L., Ginhoux, F., & Ho, I. A. (2026). NF1 Leucine Rich Domain‐Derived Extracellular Vesicles Remodel the Glioblastoma Immune Microenvironment via an ADAM17‐Associated Inflammatory Program. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70355

Vancouver

Vijayanathan Y, Yeo JY, Tan JH, Mohamed FB, Lee B, Kozaki T, et al. NF1 Leucine Rich Domain‐Derived Extracellular Vesicles Remodel the Glioblastoma Immune Microenvironment via an ADAM17‐Associated Inflammatory Program. Journal of Extracellular Vesicles. 2026. doi:10.1002/jev2.70355

BibTeX
@article{Vijayanathan2026,
  author = {Vijayanathan, Yuganthini and Yeo, Jacqueline Yt and Tan, Janice Hy and Mohamed, Fikri Bin and Lee, Bernett and Kozaki, Tatsuya and Halim, Nurashikin Abdul and Ho, Rachel Ly and Tu, Hai Tao and Zhang, Zhi Wei and Sarkaria, Jann N and Zeng, Li and Ginhoux, Florent and Ho, Ivy Aw},
  title = {NF1 Leucine Rich Domain‐Derived Extracellular Vesicles Remodel the Glioblastoma Immune Microenvironment via an ADAM17‐Associated Inflammatory Program},
  journal = {Journal of Extracellular Vesicles},
  year = {2026},
  doi = {10.1002/jev2.70355}
}
Kostenlos starten →